Matrixyl 3000 Promotional Sheet Usa

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Face

MATRIXYL 3000
TM

Make-uup

Patented

Pal-G
GHK and Pal-G
GQPR

Function:

Anti-wrinkling and lifting effect

Definition:

MatrixylTM3000 contains two


matrikines, Pal-GHK and PalGQPR which act in synergy to
restore and maintain skin's
youthful appearance.

Properties:

MatrixylTM3000 contains
matrikines which are
messengers of cutaneous
restructuration and repair. They
activate the neosynthesis of
extracellular matrix
macromecules providing
MatrixylTM3000 with a visible
anti-wrinkle efficacy.

Characteristics:

As messenger molecules,
matrikines are capable of
regulating cell activities. They
interact with specific receptors
to activate certain genes
involved in the process of
extracellular matrix renewal
and cell proliferation. With age
these mechanisms become
progressively weaker.

INCI Name:

Glycerin - Butylene Glycol Aqua (Water) - Carbomer Polysorbate-20 Palmitoyl Oligopeptide Palmitoyl Tetrapeptide-3

Applications:

Anti-aging , face lifting and


wrinkle treatment products.
Suitable for gels, serums
lotion, creams.

Formulation:
Water soluble

Recommended use level:

3 to 8%

Sederma - member of Croda International Group

Copyright 2004 by Sederma, Inc. All rights reserved.

CLAIM SUBSTANTIATION

January 2004

in vitro tests
Synthesis of matrix macromolecules
Study to determine ability of fibroblasts
incubated for 72 hours with MatrixylTM3000 (1,
3,and 5%) to stimulate synthesis of
extracellular matrix components.
Stimulation of gene expression
Study to evaluate regulation of dermal and
epidermal genes by matrikines present in
MatrixylTM3000, using DNA-Array techniques
on a reconstructed epidermis and a fibroblast
culture.

Stimulation of synthesis (%)

In vitro
Collagen 1

70

Fibronectin

Hyaluronic Acid

60
50
40
30
20
10
0

Concentration of MatrixylTM3000 (%)

The profile of gene activation by the


matrikines in Matrixyl3000 complement
the skin's natural mechanisms for cutaneous
restructuring.

in vivo tests
Visible and measurable proof of anti-wrinkle efficacy
Clinical study in which 2 panels of 23 volunteers aged 39 to 74 applied a cream containing 3%
Matrixyl3000 to one-half of their face against a placebo or 3% Matrixyl on the other half twice a day
for 56 days. Anti-wrinkling and lifting efficacy was assessed by profilometry and photography, as
compared to T0.
Variation of parameters compared to T0 (%)
MatrixylTM3000

Surface occupied by deep wrinkles (>200m)


Main wrinkle density
Main wrinkle average depth
Main wrinkle average volume
Roughness
Complexity (Lifting effect)
ns : non significant

*significant / T0 (p<0.05)

44.9
37.0**
15.1**
18.5**
14.4**
16.6**
**

MatrixylTM

Placebo

-27.7**
-27.3*
-9.8**
-14.7**
-10.8**
-12.7**

4.3
-9.6
-3.2
-8.7*
1.4
4.2

ns
ns
ns

ns
ns

**significant /T0 (p<0.01)

In vivo

Effect on skin elasticity and tone

T0 MATRIXYLTM

T56 MATRIXYLTM

Assessement of elasticity and tone by


cutometry using the same panel as above.
+ 19.5%

Variation / T0 (%)

20
15
10
5
0

MatrixylTM 3000
MatrixylTM

*
*

Placebo

significant / T0

**
Elasticity

T0 MATRIXYLTM3000

T56 MATRIXYLTM3000

Tone

MatrixylTM3000 displays major and


significant improvements in elasticity
and tone.

Sederma Inc

E-mail: [email protected]

www.crodausa.com

Tel 732-692-1652

Fax 732-417-0804

You might also like